A veteran biostatistician on the planning document and the dose-selection shortcut that quietly decide whether trials succeed.
- The Vendor Questions Most Clinical Tech Buyers Forget To Ask
- AI In Clinical Trials: Stop Hyping It, Start Proving It
- What AI Can't Fix In Decentralized Clinical Trial Data
- Decentralized Trials Promised Less Burden. Did They Deliver?
- Wireless Connectivity Is A Data Integrity Issue, Not IT
- Why Clinical AI Validation Needs Portability Testing Beyond A Single Accuracy Score
- The Synchronization Problem Clinical Research Isn't Watching
- Why Ophthalmology Trials Are Clinical Research's Toughest Tech Test
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
How Automated Site Payment Solutions Are Revolutionizing Clinical Trials
Discover how a specialized site payment solution can streamline your clinical trials, enhance site engagement, and deliver measurable financial benefits.
-
When "Everything" Is The Pain Point: Rethinking RTSM For Real-World Use
RTSM friction often comes from complexity, limited flexibility, and siloed data. Discover approaches that improve visibility, forecasting, and operational efficiency across clinical trials.
-
Beyond the Acronyms: What Today's Trials Really Need From RTSM
Consider how resin selection, process optimization, and system qualification create scalable workflows that meet evolving regulatory and operational demands in modern biomanufacturing.
-
Central eSource Is The Latest In Sponsor Provided Site Offerings
For decades, sponsors have provided tools to help clinical sites work more efficiently. Central eSource is the latest evolution in this trend.
-
How To Improve Patient Engagement In Clinical Trials
Stronger patient engagement improves recruitment, retention, and data quality. Reducing burden, improving communication, and meeting real needs can transform trials and keep studies on track.
-
Fulfilling MDR Requirements For A Groundbreaking Microsurgery Robot
Discover the help a company pioneering the field of open surgery received to advance their robotic technology, replacing their former EDC system to improve their clinical research efficiency.
-
Commercializing Rare Disease Treatment With Near Real-Time Alerts
How did Quest help a leading pharmaceutical company overcome the data latency challenges associated with traditional EHR when recruiting eligible patients for a rare blood disorder drug?
-
Expedite Drug Development With An Integrated CDMO-CRO Model
From optimizing first-in-human strategies to leveraging AI-enabled digital architectures, the integrated CDMO-CRO services model reduces risk and maximizes program value.
-
How Optina Diagnostics Used EDC In Earlier Disease Detection
Understand how Optina Diagnostics streamlined operations and achieved significant milestones by leveraging Castor's tools in its effort to revolutionize the diagnostic process for Alzheimer’s.
-
eSource For A COVID Treatment Trial
Unearth how this emerging biopharmaceutical company was able to overcome challenges to successfully facilitate a Phase 2 trial for a COVID-19 treatment in critically ill patients.
RECENT NEWSLETTERS
- 09.05.26 -- Best Of August: AI, FDA RWE, And Trial Data Risks
- 09.03.26 -- AI, APIs, and eConsent Are Exposing Trial Workflow Gaps
- 08.27.26 -- Patient Data Breaks Down When Trial Systems Miss Reality
- 08.20.26 -- Clinical AI Validation, Trial Handoffs, And Smarter Study Builds
- 08.13.26 -- AI Urgency, Site-Sponsor Gaps, And Data That Saves Lives